To Determine Safety and Tolerability of MG-S-2525 and to Evaluate Its PK Profile in Healthy Volunteers
- First Posted Date
- 2018-08-28
- Last Posted Date
- 2020-09-02
- Lead Sponsor
- Metagone Biotech Inc.
- Target Recruit Count
- 81
- Registration Number
- NCT03650075
- Locations
- 🇨🇳
Taipei Medical University Hospital, Taipei, Taiwan
Assess the Safety and Activity of Combined MG005 and Sorafenib (NEXAVAR®) Treatment With Solid Tumor
- First Posted Date
- 2018-01-23
- Last Posted Date
- 2021-04-26
- Lead Sponsor
- Metagone Biotech Inc.
- Target Recruit Count
- 17
- Registration Number
- NCT03406364
- Locations
- 🇨🇳
Tri-Service General Hospital, Taipei, Nehu District, Taiwan
© Copyright 2025. All Rights Reserved by MedPath